Company Filing History:
Years Active: 1995-2013
Title: Hitoshi Ohmori: Innovator in Antibody Research
Introduction
Hitoshi Ohmori is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on methods for selecting antibody-producing cells, which has implications for various medical applications.
Latest Patents
One of his latest patents involves methods for specifically selecting antibody-producing cells. This method includes culturing B cells that can undergo cell death under specific conditions, while also being able to suppress this cell death through signals generated by the binding of an antigen to the antibody on the B cell surface. This innovative approach allows for the selection of viable antibody-producing B cells that bind with the antigen. Another significant patent pertains to human novel cDNA and TGF-beta superfamily proteins encoded thereby, which includes isolated cDNAs derived from mRNAs expressed in human cells. These cDNAs encode proteins that exhibit functions similar to known proteins, providing valuable insights into immunosuppressive agents.
Career Highlights
Hitoshi Ohmori has worked with reputable organizations such as Sagami Chemical Research Center and Taiho Pharmaceutical Company Limited. His experience in these institutions has contributed to his expertise in the field of biotechnology and antibody research.
Collaborations
Throughout his career, Hitoshi has collaborated with notable colleagues, including Seishi Kato and Suwan Oh. These collaborations have further enriched his research and innovations in the field.
Conclusion
Hitoshi Ohmori's contributions to antibody research and his innovative methods for selecting antibody-producing cells highlight his importance as an inventor. His work continues to influence the field and pave the way for future advancements in biotechnology.